Clinical Trial Update: Flumazenil for the Treatment of Primary Hypersomnia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of flumazenil for primary hypersomnia completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersomnia
• Idiopathic Hypersomnia
• Narcolepsy Without Cataplexy

Drugs mentioned

• Flumazenil (flumazenil)

Snippet

Sponsor: Lynn Marie Trotti | Conditions: Hypersomnia, Primary Hypersomnia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-27